Sign in
4

Changes in Ownership

Compass Therapeutics, Inc. Filed Acc 0001171843-22-002945

Options or other derivatives

  • Director acquired 45,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Chiniara Ellen Director 2022-04-26 Grant or award · Stock Option (Right to Buy) +45,000 45,000 D
Loading xslF345X03/ownership.xml…